Co-Investigator in Global Multicentre Phase II trial - GI-5005 Therapeutic Vaccine plus Peg-IFN/Ribavirin Improves End of treatment response at 48 Weeks Versus Peg-IFN/Ribavirin in NaÃ¯ve Genotype 1 Chronic HCV Patient 2008.
Co-Investigator in Global Multicentre Phase II trial - An evaluation of 2 dose routes of HDV Interferon (HDV-IFN) Administered with Ribavirin in the treatment of Chronic Hepatitis C Non-responder and Naive Hepatitis C patients. 2008.
Co-Investigator in Global Multicentre Phase III trial - Open labeled, randomised, multicentre, active-controlled, dose ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every 4 weeks plus ribavirin in interferon alfa-naive patients with genotype 2/3 chronic hepatitis C. 2009.
Co-Investigator in Global Multicentre Phase II trial - Randomised, double-blind, placebo-controlled, Phase 2b study to assess the safety and efficacy effects of Art-123 on subjects with sepsis and disseminated intravascular coagulation. 2010.
Principle Investigator in Nationwide Multicentre Phase III trial - Single dose delayed released Mesalamine in moderately active Ulcerative Colitis. 2011.
Co-Investigator in Nationwide Multicentre Phase IV trial â€“ Open label study to evaluate the safety and efficacy of Amphotericin B lipid suspension for injection (Amfy) in immunocompromised patients with Invasive fungal infections (IFI). 2011.
Co-Investigator in THE APPROACH STUDY â€“ Safety and efficacy of Boceprevir in combination with Peg Interferon plus Ribavirin for treatment of Asia Pacific Subjects with Chronic Hepatitis C Genotype 1 who failed prior treatment with Pegylated Interforon plus Ribavirin 2013. [Ongoing trial]
Critical Care Issues in Adult Liver Transplantation. Palepu B Gopal, Dharmesh Kapoor, Ravichandra Raya, M Subrahmanyam, Deven Juneja, B Sukanya. Departments of Anesthesia and Critical Care Medicine, and Gastroenterology, Global Hospital, Lakdi-ka-pul, Hyderabad. IJCCM. 2009; Vol 13; Iss 3; pp. 113-119.
Mycophenolatemofetil-induced Colitis with Graft versus Host Disease-like Features in a Liver Transplant Recipient. Patra S, Vij M, Sukanya B, Kapoor D. Indian J Pathol Microbiol. 2012 Oct-Dec; 55(4):506-8. doi: 10.4103/0377-4929.107792.
Book Chapter: Acute Liver Failure. In: Textbook of Gastroenterology by Rajiv Mehta. 2nd Edition, Paras Publishers, 2008.
Book Chapter: Renal Dysfunction in Liver Disease. In: Textbook of Gastroenterology by Rajiv Mehta. 2nd Edition, Paras Publishers, 2008.
De Novo Hepatocellular Carcinoma in a Patient on Entecavir - A Case Report. ISGCON 2009, Kolkata.
Poster Presentation: Results of Paediatric Liver Transplantation in South India. Asia Pacific Digestive Week, APDW 2008. New Delhi. Received citation and cash award for this poster.
Early Post-Operative Infections Following Orthotopic Liver Transplantation - Results from a Single Centre. ISGCON 2006, Mumbai.
Recrudescence of DNA Viruses in the Immunosupressed State - Results from Post Liver Transplant Patients. ISGCON 2006, Mumbai.
Poster Presentation: Extracorporeal Albumin Dialysis Using MARS - Results from a Single Centre. ISGCON 2005, Visakhapatnam. This poster was selected as one of the Presidential Posters in this conference.